Should clinical trials with concurrent economic analyses be blinded?
JAMA
.
1997 Jan 1;277(1):63-4.
Authors
N Freemantle
1
,
M Drummond
Affiliation
1
Centre for Health Economics, University of York, England. nf2@york.ac.uk
PMID:
8980212
No abstract available
MeSH terms
Clinical Trials as Topic*
Costs and Cost Analysis*